Eye Allergy Itch Relief
NDC 75907-343, olopatadine hydrochloride ophthalmic, solution, from Dr. Reddy's Laboratories Inc..
- Product NDC
- 75907-343
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Inc.
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213514
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75907-343 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLOPATADINE HYDROCHLORIDE7 mg/mL
Pharmacologic classes
Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75907-343-25 | 75907034325 | 2 BOTTLE in 1 CARTON (75907-343-25) / 2.5 mL in 1 BOTTLE (75907-343-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 75907-343 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75907-343 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75907-343. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.